Investing in Biomerica, Inc. (BMRA)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)0.6242
Intrinsic value (DCF)0.5833
Graham-Dodd Method0.00-100
Graham Formula0.00-100

Company description

BMRA, or BioMedical Research Alliance, is a company that specializes in developing innovative diagnostic tests for healthcare professionals. Founded in 2016, the company has made significant strides in the medical industry by creating cutting-edge solutions that assist in early detection and personalized patient care. BMRA's patented technologies utilize advanced biomarkers and genetic analysis to identify potential diseases and track treatment progress. By partnering with leading research institutions and pharmaceutical companies, BMRA has been able to expand its reach globally and establish itself as a trusted leader in diagnostic testing. In addition to their diagnostic work, BMRA also invests in developing therapeutics for diseases such as cancer and neurological disorders. With a dedicated team of scientists, researchers, and industry experts, BMRA is continuously pushing the boundaries of medical technology to improve patient outcomes and revolutionize the healthcare sector. As a publicly-traded company with the ticker BMRA, investors can trust in the company's track record of success and potential for future growth.